Compare Dell Technologies Inc (DELL) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dell Technologies Inc vs TransMedics Group Inc — how do they compare? Dell Technologies Inc trades at $586.28 (market cap $365.31B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: Dell Technologies Inc is far larger — about 133.3× TransMedics Group Inc's market cap, and Dell Technologies Inc pays a 0.44% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dell Technologies Inc for 57 Days and TransMedics Group Inc for 24 Days on average.
| DELL | TMDX | |
|---|---|---|
Market Cap | $365.31B | $2.74B |
Volume | 5,121,365 | 949,331 |
Sector | Technology | Health |
52-Week High | $588.67 | $150.42 |
52-Week Low | $111.10 | $61.99 |
Typical Hold Time | 57 Days | 24 Days |
Enterprise Value | $388.20B | $3.13B |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dell Technologies trades at $574.74, down 0.73% on the day, with strong bullish momentum driven by AI server demand. The stock shows robust earnings performance with three consecutive quarterly beats and raised 2027 AI revenue guidance to $74 billion. Technical indicators signal bullish momentum while fundamentals reveal strong revenue growth and improving profit margins, though valuation multiples appear elevated.
Outlook remains positive with AI server backlog reaching $95 billion and institutional support, though risks include execution challenges and competitive pressures in the rapidly evolving AI infrastructure market. The stock trades near analyst consensus target of $566.35 with upside potential to $735 based on AI-driven growth prospects.
TransMedics Group (TMDX) trades at $79.00, down 2.55% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with 58.69% gross margins and 22.69% net income margins, though profitability declined year-over-year. Recent news highlights insider buying, CFO appointment, and ongoing legal investigations into fiduciary duties, creating conflicting sentiment signals.
While analyst consensus remains bullish with a $99.75 price target, near-term risks include margin pressure from heavy investments and legal uncertainties. The stock's current valuation at 20.47 P/E offers potential upside if execution improves, but investors face volatility from earnings misses and regulatory scrutiny.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dell Technologies Inc
VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses
Read more on DELL →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
